In another answer, you responded the top-5 pharmaceutical companies
(by revenue) are those listed below.  Could you please determine what
percentage of each of their 2002 revenue went into each of the
following 4 categories:
1. Sales/marketing (of any type - conferences, drug-reps,
doctor-brochures, free-samples, or whatever)
2. Legal costs (patent maintenance, lawsuits,...)
3. R&D toward future drugs 
4. Product Production

Companies & 2002 revenue:
1. Merck & Co. (USD 51,790.3 million) 
2. Johnson & Johnson (USD 36,298 million) 
3. Pfizer, Inc. (USD 32,373 million) 
4. GlaxoSmithKline, plc  (USD 31,819 million)  
5. Bristol-Myers Squibb Co. (USD 21,717.0 million)

---

Request for Question Clarification by omnivorous-ga on 13 Oct 2003 17:02 PDT

Mark1075 --

Having looked at many pharmaceutical financial statements, you'll find
the data readily available for all but the legal expenses (though I'd
be glad to check).  If you'd be satisfied with 1, 2 and 4, then I (or
another researcher) should be able to answer this question.

Best regards,

Omnivorous-GA

---

Clarification of Question by mark1075-ga on 13 Oct 2003 23:38 PDT

Okay, if you could provide me with the table of that information along
with the links to the relevant reports (if they're available online)
that would be sufficient to answer the question.  Though, for a 5-star
rating, if you could offer some intelligent suggestions regarding (1)
how I might roughly estimate the legal-expenses, and (2) whether the
company has any interest in "fudging" these various ratios (e.g. might
they receive tax-benefits for medical research not present for
marketing?  Might this cause them to categorize a "research study"
they funded to promote their product as R&D instead of marketing?) 
Thanks.